Theravance Biopharma, Inc.·4

Jun 25, 6:06 PM ET

Winningham Rick E 4

4 · Theravance Biopharma, Inc. · Filed Jun 25, 2025

Insider Transaction Report

Form 4
Period: 2025-06-23
Winningham Rick E
DirectorCHIEF EXECUTIVE OFFICER
Transactions
  • Gift

    Ordinary Shares

    2025-06-2320,0001,733,180 total
Holdings
  • Ordinary Shares

    (indirect: By Trust)
    92,567
  • Ordinary Shares

    (indirect: As Custodian)
    13,500
Footnotes (1)
  • [F1]Bona Fide Gift. No compensation was given to the donor for the gifting of shares.

Documents

1 file
  • 4
    form4-06252025_100657.xmlPrimary